CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Truist Securities Adjusts Regeneron Pharmaceuticals Price Target to $769 From $778

Neutral
AI Analysis

Summary

Truist Securities reduced its price target for Regeneron Pharmaceuticals from $778 to $769, representing a modest downward adjustment to the analyst's valuation estimate.

Importance:2/10
Sentiment:
-0.20
price_targetanalyst_coveragevaluation
Related Companies

Read the original article

Published by yahoo_finance on July 7, 2026 12:53 PM

Read Original